Premium Reports
 Download Report Brief  Download Full Report    Zoom in charts

Preferences

   Bookmark

Related Series

Integration Engines 2015
|
2015
Interface Engines
|
2011
Interface Engine Market Review 2006
|
2006

 End chart zoom
Integration Engine Market Review 2007 Integration Engine Market Review 2007
* A page refresh may be necessary to see the updated image

Integration Engine Market Review 2007

January 29, 2007

Current Time Inside Cache Tag Helper: 10/20/2021 5:34:42 PM and Model.reportId = 394

What level of satisfaction are providers reporting with their Interface Engine product? Who are the highest ranking Interface Engine vendors? Which regions are receiving better service for their Interface Engine solution?

HtmlReportContent Current Time Inside Cache Tag Helper: 10/20/2021 5:34:42 PM and Model.reportId= 394 and Model.HtmlReportContent_LastWriteTimeUtcInTicks=637406508715326818

KLAS’ recently-released Interface Engine Market Review answers these questions and provides valuable insight into the evolving interface engine market. The 171-page report provides a snapshot of today’s Interface Engine vendors, compares their strengths and weaknesses against one another and the KLAS HIT average (the average of all Healthcare Information Technology products in the KLAS database).

This report includes a total of ten products from nine vendors, including:

  • Eclipsys eLink
  • Intersystems Ensemble
  • Oracle SOA Suite
  • Orion Rhapsody
  • Quovadx Cloverleaf
  • Siemens OPENLink
  • Sun eGate
  • Sun eGate 5-ICAN Suite
  • Sybase e-Biz Impact
  • TC Software ConnectMate
 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2021 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.